<DOC>
	<DOCNO>NCT01234636</DOCNO>
	<brief_summary>Cardiovascular disease major cause mortality worldwide result one three global death . One main characteristic cardiovascular disease impair blood flow increase formation clot . Platelets clot-forming cell responsible prevention bleeding . However , disease state may overly activate tend stick , promote blood clot blockage vessel . Conjugated linoleic acid ( CLA ) unique fatty acid present dairy food product beef would help prevent platelet clot thus help prevent cardiovascular disease . However , mechanism fatty acid affect platelet function yet fully understood . We design human intervention study assess mechanism CLA beneficially affect platelet function marker haemostasis inflammation human .</brief_summary>
	<brief_title>Conjugated Linoleic Acid Supplementation Study</brief_title>
	<detailed_description>Despite trans fatty acid , dietary conjugate linoleic acid ( CLA ) associate decreased atherogenesis , beneficial effect insulin sensitivity , glucose lipid profile body composition animal studies.Todate study study effect two individual CLA isomer body composition , lipoprotein metabolism immune function , inflammation , insulin sensitivity oxidative stress human . A previous study reveal cis9 , trans11 trans10 , cis12 CLA , well CLA mix , significantly decrease agonist-induced platelet aggregation TxB2 production ex vivo compare linoleic acid . No effect agonist-induced platelet aggregation blood clot parameter healthy female volunteer observe upon supplementation 3.9 g/d CLA , compare sunflower oil , may due low number subject participate study . Indeed , supplementation 13.0 g/day CLA mix - 50:50 blend , compare placebo oil , significantly decrease fibrinogen level type 2 diabetes patient , fibrinogen plasminogen activator inhibitor-1 level significantly low upon intervention CLA milk ( 4.7 g/d cis9 , trans11 CLA 0.4 g/d trans10 , cis12 CLA ) , compare CLA mix ( 2.3 g/d cis9 , trans11 CLA 2.2 g/d trans10 , cis12 CLA ) , low compare olive oil , postmenopausal women.Thus overall evidence indicate especially cis9 , trans11 CLA isomer may prevent platelet activation aggregation , possibly display anticoagulant property . However , far assessed detail . In study assess effect supplementation cis9 , trans11 CLA-rich oil platelet function measure platelet aggregation also vitro coagulation platelet activation healthy overweight human . In addition , examine effect CLA supplementation plasma cellular marker inflammation oxidative stress .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>â€¢ Healthy men woman age 3574 year blood pressure 160/90 mmHg ; fast plasma glucose &lt; 7 mmol/L ; total cholesterol &lt; 8 mmol/L , cholesterol/HDL ratio &lt; 6 and/or ASSIGN score &lt; 20 % ) platelet count &gt; 170x109/L haematocrit 40 % male 35 % female haemoglobin 130 g/L male 115 g/L female 1020 % risk develop cardiovascular disease within next 10 year base ASSIGN calculation ( http : //cvrisk.mvm.ed.ac.uk/index.htm ) include follow factor : age , gender , number cigarette smoke per day , Scottish Index Multiple Deprivation ( SIMD ) /postcode , systolic blood pressure , level total HDL cholesterol family history cardiovascular disease least one additional risk factor 50 year old , BMI 25 kg/m2 , elevate triglyceride level ( &gt; 1.7 mmol/L ) elevate glucose level ( &gt; 5.6 mmol/L ) ; Exclusion criterion Subjects exclude They regularly take aspirin aspirincontaining drug , antiinflammatory drug ; They take drug herbal medicine know alter platelet function haemostatic system general ; They diagnose diabetes , hypertension , renal , hepatic , haematological disease coronary heart disease ; They undertake 6 hour vigorous exercise per week They pregnant ( plan become pregnant ) lactate ; They give pint blood transfusion purpose within last month ; They unsuitable vein blood sample ; They inability understand participant information sheet inability speak , read understand English language .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Platelets</keyword>
	<keyword>Platelet aggregation</keyword>
	<keyword>Platelet activation</keyword>
	<keyword>Platelet function</keyword>
	<keyword>Light transmission aggregometry</keyword>
	<keyword>Flow cytometry</keyword>
	<keyword>Platelet function analyzer-100 ( PFA-100 )</keyword>
	<keyword>Linoleic acid , conjugate</keyword>
	<keyword>cis9 , trans11 conjugate linoleic acid</keyword>
	<keyword>dietary supplement</keyword>
	<keyword>short-term intervention</keyword>
</DOC>